Jay Moorin - Net Worth and Insider Trading

Jay Moorin Net Worth

The estimated net worth of Jay Moorin is at least $18 Million dollars as of 2024-04-24. Jay Moorin is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 2,663,854 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $18 Million. Jay Moorin is the 10% Owner of Agile Therapeutics Inc and owns about 2,531 shares of Agile Therapeutics Inc (AGRX) stock worth over $914. Jay Moorin is also the Director of Novation Companies Inc and owns about 463,819 shares of Novation Companies Inc (NOVCQ) stock worth over $46. Details can be seen in Jay Moorin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jay Moorin has not made any transactions after 2016-01-27 and currently still holds the listed stock(s).

Transaction Summary of Jay Moorin

To

Jay Moorin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay Moorin owns 10 companies in total, including UroGen Pharma Ltd () , Eagle Pharmaceuticals Inc () , and Agile Therapeutics Inc () among others .

Click here to see the complete history of Jay Moorin’s form 4 insider trades.

Insider Ownership Summary of Jay Moorin

Ticker Comapny Transaction Date Type of Owner
UroGen Pharma Ltd 2017-05-09 10 percent owner
Eagle Pharmaceuticals Inc 2015-05-06 director & 10 percent owner
Agile Therapeutics Inc 2016-01-27 10 percent owner
Arno Therapeutics Inc 2016-01-12 director
Immune Design Corp 2015-05-12 10 percent owner
NovaDel Pharma Inc 2011-04-04 10 percent owner
Achillion Pharmaceuticals Inc 2009-12-17 10 percent owner
Paratek Pharmaceuticals Inc 2006-05-03 director
Palatin Technologies Inc 2005-11-29 10 percent owner
Molecular Templates Inc 2005-02-04 10 percent owner

Jay Moorin Latest Holdings Summary

Jay Moorin currently owns a total of 3 stocks. Among these stocks, Jay Moorin owns 2,663,854 shares of Achillion Pharmaceuticals Inc (ACHN) as of December 17, 2009, with a value of $18 Million and a weighting of 99.99%. Jay Moorin owns 2,531 shares of Agile Therapeutics Inc (AGRX) as of January 27, 2016, with a value of $914 and a weighting of 0.01%. Jay Moorin also owns 463,819 shares of Novation Companies Inc (NOVCQ) as of May 15, 2006, with a value of $46 and a weighting of 0%.

Latest Holdings of Jay Moorin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACHN Achillion Pharmaceuticals Inc 2009-12-17 2,663,854 6.76 18,007,653
AGRX Agile Therapeutics Inc 2016-01-27 2,531 0.36 914
NOVCQ Novation Companies Inc 2006-05-15 463,819 0.00 46

Holding Weightings of Jay Moorin


Jay Moorin Form 4 Trading Tracker

According to the SEC Form 4 filings, Jay Moorin has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 563,452 shares on December 17, 2009, which brought Jay Moorin around $2 Million.

According to the SEC Form 4 filings, Jay Moorin has made a total of 0 transactions in Agile Therapeutics Inc (AGRX) over the past 5 years. The most-recent trade in Agile Therapeutics Inc is the acquisition of 197 shares on January 27, 2016, which cost Jay Moorin around $3 Million.

According to the SEC Form 4 filings, Jay Moorin has made a total of 0 transactions in Novation Companies Inc (NOVCQ) over the past 5 years. The most-recent trade in Novation Companies Inc is the acquisition of 96,154 shares on May 15, 2006, which cost Jay Moorin around $3 Million.

Insider Trading History of Jay Moorin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jay Moorin Trading Performance

GuruFocus tracks the stock performance after each of Jay Moorin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jay Moorin is -7.79%. GuruFocus also compares Jay Moorin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jay Moorin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jay Moorin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jay Moorin

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.59 -7.79 0.28 -72.49 -57.6 -63.46
Relative Return to S&P 500(%) -6.84 -13.08 -11.2 -91.38 -71.79 -63.62

Jay Moorin Ownership Network

Ownership Network List of Jay Moorin

No Data

Ownership Network Relation of Jay Moorin


Jay Moorin Owned Company Details

What does UroGen Pharma Ltd do?

Who are the key executives at UroGen Pharma Ltd?

Jay Moorin is the 10 percent owner of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include Chief Medical Officer Mark Schoenberg , General Counsel Jason Drew Smith , and Chief Financial Officer Dong Kim .

UroGen Pharma Ltd () Insider Trades Summary

Over the past 18 months, Jay Moorin made no insider transaction in UroGen Pharma Ltd (). Other recent insider transactions involving UroGen Pharma Ltd () include a net sale of 21,736 shares made by Mark Schoenberg , and a net sale of 15,422 shares made by Jason Drew Smith .

In summary, during the past 3 months, insiders sold 29,564 shares of UroGen Pharma Ltd () in total and bought 0 shares, with a net sale of 29,564 shares. During the past 18 months, 37,158 shares of UroGen Pharma Ltd () were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,158 shares.

UroGen Pharma Ltd ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

UroGen Pharma Ltd Insider Transactions

No Available Data

Jay Moorin Mailing Address

Above is the net worth, insider trading, and ownership report for Jay Moorin. You might contact Jay Moorin via mailing address: C/o Proquest Investments, L.p, 2430 Vanderbilt Beach Road, #108 - 190, Naples Fl 34109.

Discussions on Jay Moorin

No discussions yet.